Back

Age- and sex- differences in efficacy of treatments for type 2 diabetes: Network meta-analysis of aggregate and individual level data

2024-06-24 endocrinology Title + abstract only
View on medRxiv
Show abstract

ImportanceSodium glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor analogues (GLP1ra) and dipeptidyl peptidase-4 inhibitors (DPP4i) improve hyperglycaemia and, in the case of SGLT2i and GLP1ra, reduce the risk of major adverse cardiovascular events (MACE) in type 2 diabetes. It is not clear whether efficacy varies by age or sex. ObjectiveAssess whether age or sex are associated with differences in efficacy of SGL2i, GLP1ra and DPP4i. Data sourcesMedline, Embase and ...

Predicted journal destinations